Tim McCarthy, Chairman of ImmuPharma – 17th May 2017
22nd May 2017 - 2:22 pmTim McCarthy, Chairman of ImmuPharma gives an update, on its lead compound, Lupuzor™ in its pivotal Phase III study on this audio podcast
Tim McCarthy, Chairman of ImmuPharma gives an update, on its lead compound, Lupuzor™ in its pivotal Phase III study on this audio podcast